This is further supported by synergistic anticancer effects of sorafenib and ursolic acid, suggesting that the depletion of cancer cells can be attributed to selective apoptosis and ferroptosis considering the regulatory effect on the Nrf2 pathway [298]. This evidence concerns the gene NFE2L2 and cancer.